Green Cross Lab Cell Corporation Cash Flow Conversion Efficiency
Green Cross Lab Cell Corporation cash flow conversion efficiency. Based on the latest financial reports, Green Cross Lab Cell Corporation (144510) has a cash flow conversion efficiency ratio of 0.001x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩208.25 Million ≈ $141.13K USD) by net assets (₩189.35 Billion ≈ $128.32 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Green Cross Lab Cell Corporation (2015–2025)
Cash flow conversion efficiency of Green Cross Lab Cell Corporation from 2015 to 2025. This chart illustrates how Green Cross Lab Cell Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Green Cross Lab Cell Corporation stock quote for real-time trading data and today's change.
Green Cross Lab Cell Corporation Cash Flow Conversion Ratio Explained
Green Cross Lab Cell Corporation cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Green Cross Lab Cell Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Green Cross Lab Cell Corporation ranked by their cash flow conversion efficiency. Also see 144510 market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Odlewnie Polskie SA
WAR:ODL
|
0.063x |
|
The Hi-Tech Gears Limited
NSE:HITECHGEAR
|
0.043x |
|
Asia Pacific Satellite Inc
KQ:211270
|
0.011x |
|
SaltX Technology Holding AB
ST:SALT-B
|
-0.078x |
|
Samyang Packaging
KO:272550
|
0.045x |
|
Ulusoy Un Sanayi ve Ticaret AS
IS:ULUUN
|
-0.156x |
|
LINMON MEDIA LTD -000025
F:8MN
|
N/A |
|
Hiap Teck Venture Bhd
KLSE:5072
|
-0.022x |
Annual Cash Flow Conversion Efficiency for Green Cross Lab Cell Corporation (2015–2025)
The table below shows the annual cash flow conversion efficiency of Green Cross Lab Cell Corporation from 2015 to 2025. Review free cash flow generation of Green Cross Lab Cell Corporation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩190.38 Billion ≈ $129.02 Million |
₩9.19 Billion ≈ $6.23 Million |
0.048x | +94.89% |
| 2024-12-31 | ₩457.79 Billion ≈ $310.24 Million |
₩11.34 Billion ≈ $7.69 Million |
0.025x | +265.48% |
| 2023-12-31 | ₩541.48 Billion ≈ $366.95 Million |
₩3.67 Billion ≈ $2.49 Million |
0.007x | -94.50% |
| 2022-12-31 | ₩538.46 Billion ≈ $364.91 Million |
₩66.42 Billion ≈ $45.01 Million |
0.123x | +163.63% |
| 2021-12-31 | ₩511.00 Billion ≈ $346.30 Million |
₩23.91 Billion ≈ $16.20 Million |
0.047x | -75.73% |
| 2020-12-31 | ₩47.17 Billion ≈ $31.97 Million |
₩9.09 Billion ≈ $6.16 Million |
0.193x | +3707.58% |
| 2019-12-31 | ₩44.05 Billion ≈ $29.85 Million |
₩223.04 Million ≈ $151.15K |
0.005x | -50.78% |
| 2018-12-31 | ₩47.72 Billion ≈ $32.34 Million |
₩490.92 Million ≈ $332.69K |
0.010x | -82.63% |
| 2017-12-31 | ₩48.32 Billion ≈ $32.75 Million |
₩2.86 Billion ≈ $1.94 Million |
0.059x | +1059.97% |
| 2016-12-31 | ₩48.10 Billion ≈ $32.59 Million |
₩-296.65 Million ≈ $-201.04K |
-0.006x | -103.71% |
| 2015-12-31 | ₩8.96 Billion ≈ $6.07 Million |
₩1.49 Billion ≈ $1.01 Million |
0.166x | -- |
About Green Cross Lab Cell Corporation
GC Cell Corporation develops cell therapy products. It also provides cell banking, sample inspection, clinical trial, and bio logistics services. Its main product is Immuncell-LC. GC Cell Corporation has strategic agreement with Lukas Biomedical Co., Ltd. to develop Cell therapy. The company was formerly known as Green Cross Lab Cell Corporation and changed its name to GC Cell Corporation in Nove… Read more